High Purity Pharmaceutical Grade 857890-39-2 Lenvatinib mesylate ad Cancrum
Productumnomen | Lenvatinib mesylate |
Synonyma | 4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide monomethanesulfonatus |
CAS Non. | 857890-39-2 |
Aspectus | Pallida lutea in albo crystallino pulveris |
Formulae hypotheticae | C21H19ClN4O4.CH4O3S |
M. Pondus | 522.96 |
Consuetudinem | Investigationis proposito |
stipare | Quod per petitio tua |
Repono | Serva in stricta, levis vasis repugnans in loco frigido |
Lenvatinib mesylateCAS;857890-39-2 | ||
ITEMS | SIGNA | Effectus |
CARACTERES | Pallida lutea in albo crystallino pulveris | Fere album crystallinum pulveris |
IDENTIFICATIO | 1、Per IR2、Per HPLC | Obsequitur |
SOLUILITAS' | Leviter solutum in aquaprope insolubilem in ethanol | Obsequitur |
AQUA | ≤1.0% | 0.26% |
RELICTUM DE IGNIS | ≤0.2% | 0.08% |
METALLIS | ≤20ppm | Obsequitur |
Substantia relativa | Quaelibet immunditia, ≤0.5% | 0.21% |
Totalis immunditias, ≤1.0% | 0.43% | |
TEMPTATIO | 98.0~102.0% | 99.3% |
Conclusio prosequitur inceptum vexillum |
Company Information
√ Procuratio accumsan plena experientia in technicis et technicis peritissimis sectatoribus; √ Quality is always our top consideration, Strict QC system; √ 11 annos periti quadrigis venditio educendi; √ Independentes R&D lab; √ Duae officinae GMP terminus signati longi sunt; √ Divites copiarum otiosorum officinarum copia pro project nativus; √ High Efficiency working team with consistent path.Epistulam tuam hic scribe et mitte nobis